AMICUS THERAPEUTICS INC shareholders Q2 2023

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 215 filers reported holding AMICUS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.

AMICUS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
D. E. Shaw & Co., Inc. 1,131,926$14,216,9900.02%
Hudson Bay Capital Management LP 155,000$1,946,8000.01%
PRUDENTIAL FINANCIAL INC 755,194$9,485,2370.01%
MetLife Investment Management, LLC 148,666$1,867,2450.01%
VOYA INVESTMENT MANAGEMENT LLC 869,829$10,925,0520.01%
PRIMECAP MANAGEMENT CO/CA/ 1,094,200$13,743,1520.01%
Ameritas Investment Partners, Inc. 23,157$290,8520.01%
OPPENHEIMER ASSET MANAGEMENT INC. 59,246$744,1300.01%
GRIMES & COMPANY, INC. 24,239$304,4420.01%
GUGGENHEIM CAPITAL LLC 103,123$1,295,2250.01%
HAZLETT, BURT & WATSON, INC. 1,000$130.01%
Leucadia National 92,285$1,159,1000.01%
AMERICAN INTERNATIONAL GROUP, INC. 134,975$1,695,2860.01%
METROPOLITAN LIFE INSURANCE CO/NY 15,121$189,9200.01%
Man Group plc 222,504$2,794,6500.01%
HARBOR INVESTMENT ADVISORY, LLC 5,324$66,8690.01%
State of New Jersey Common Pension Fund D 212,773$2,672,4290.01%
VICTORY CAPITAL MANAGEMENT INC 598,944$7,522,7370.01%
VANGUARD GROUP INC 27,024,417$339,426,6790.01%
GEODE CAPITAL MANAGEMENT, LLC 5,395,606$67,768,8310.01%
External links

This page lists AMICUS THERAPEUTICS INC's shareholders in Q2 2023. To view AMICUS THERAPEUTICS INC's shareholder history, click here.